
BUILD app launched to help doctors, patients and families understand interstitial lung disease.
Leading lung specialists from India and abroad met in Kochi on 14 and 15 November for BUILD Summit 3.0 (Bridging Unmet Needs in ILD), a two-day national conference on interstitial lung disease (ILD). The summit was organised by Amrita Vishwa Vidyapeetham, Kochi, at Vivanta by Taj, Marine Drive. Dr Asmita Mehta, Professor and Head of Respiratory Medicine, Amrita Hospital, was Course Director.
The third edition of the summit brought three internationally renowned ILD experts to Kochi as faculty: Prof Martin Kolb (McMaster University, Canada), Prof Deji Adegunsoye (University of Chicago, USA) and Prof Marlies Wijsenbeek (Erasmus MC, Netherlands). They were joined by leading pulmonologists, radiologists and pathologists from across India.
ILD is a group of more than 200 conditions that scar the lungs and cause breathlessness. Many of these diseases get worse over time. They are often diagnosed late, and getting the diagnosis right usually needs a pulmonologist, a radiologist and a pathologist to review each case together. The summit focused on these gaps in diagnosis, treatment and access to care.
Dr Prem Nair, Provost and Group Medical Director, Amrita Hospitals, inaugurated the summit by lighting the traditional lamp. He was joined by Prof Martin Kolb, Prof Deji Adegunsoye, Dr Randeep Guleria (Medanta, Gurugram), Dr Deepak Talwar (Metro Institutes of Health Sciences, Noida), Dr Sujeet Rajan (Bombay Hospital, Mumbai) and Dr Asmita Mehta.
At the ceremony, Dr Mehta launched the BUILD app (Better Understanding of ILD). The app is free for clinicians, patients and families. Doctors get HRCT learning resources, case-based quizzes, recorded multidisciplinary meetings and the BUILD prognostic score, which was developed from Indian patient data. Patients and caregivers get reliable information and support. The app is available on Google Play, and iPhone users can use it on the web at buildildapp.com.
In a milestone moment, Dr Merin Thomas received the first-ever ILD fellowship awarded by the Department of Respiratory Medicine, Amrita Hospital. She trained under Dr Mehta's mentorship. The department sees the fellowship as a step towards building a new generation of ILD specialists in India. Dr Gireesh Kumar K P, Principal, School of Medicine, felicitated the faculty of the Pan India ILD Multidisciplinary Meeting (MDM). Dr Mehta has run this online forum without a break for almost three years. Pulmonologists, radiologists and pathologists from across the country discuss difficult ILD cases there every fortnight. Those honoured included Dr Bhavin Jankharia, Dr Aparna Irodi, Dr Sujeet Rajan, Dr Sharada Nagoti, Dr (Major) Vimal Raj and Dr Pralhad Prabhudesai, along with Dr Randeep Guleria and Dr Deepak Talwar. Dr Vishnu Vazhoor proposed the vote of thanks.
Prof Kolb opened the summit with a lecture on treating fibrotic lung disease beyond today's antifibrotic drugs. Prof Adegunsoye spoke on precision medicine, biomarkers and disease subtypes in ILD. One of the most talked-about sessions was the debate “ILD as a sub-specialty: future or fallacy?” Dr Talwar argued that a dedicated ILD sub-specialty is a realistic and urgent need. Dr Guleria cautioned that it may be too ambitious for India's health system today. Dr P Sukumaran and Dr Sujeet Rajan moderated. On the second day, a three-way debate between Prof Kolb, Prof Adegunsoye and Dr Sahajal Dhooria asked whether lung function (FVC) alone is enough to judge how patients will do. Prof Marlies Wijsenbeek gave a virtual keynote on new approaches to sarcoidosis beyond steroids. Live MDM sessions over both days covered rare lung diseases, connective tissue disease, familial ILD, progressive pulmonary fibrosis and ILD with pulmonary hypertension. Expert radiologists and pathologists reviewed real cases with the audience. Two hands-on masterclasses ran on Day 1: one on reading HRCT scans, directed by Prof Kolb, and one on diagnostics beyond imaging, directed by Prof Adegunsoye.
Day 1 ended with the BUILD ILD Quiz, in which five teams of young doctors competed over five rounds: Read the Image, Connect the Dots, Build the Diagnosis, Name the Trial and Beat the Buzzer. The packed hall followed along closely.
“BUILD began in January 2024 as a dream to bring the best minds in ILD to one room and to give our patients a better chance at an early, accurate diagnosis,” said Dr Asmita Mehta. “This third edition, with the launch of the BUILD app, takes that mission beyond the conference hall to every clinician and every family living with ILD.”
The summit was accredited by the Kerala State Medical Council for 4 credit hours.


